Pinpoint Asset Management (Singapore)’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
Pinpoint Asset Management (Singapore)'s ONC Position: Q2 2026 in Review
Pinpoint Asset Management (Singapore) increased its BeOne Medicines Ltd (ONC) stake by 15% in Q2 2026, buying an estimated $412K and bringing the position to 11,009 shares worth $3.14M. The position accounts for 0.64% of the portfolio, ranked #25.
Pinpoint Asset Management (Singapore) first reported a position in ONC in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.95M in Q2 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.
- Pinpoint Asset Management (Singapore) held 11,009 shares of BeOne Medicines Ltd worth $3.14M as of Q2 2026.
- Pinpoint Asset Management (Singapore) bought 1,399 BeOne Medicines Ltd shares in Q2 2026, an estimated $412K.
- BeOne Medicines Ltd made up 0.64% of Pinpoint Asset Management (Singapore)'s portfolio in Q2 2026, its #25 holding.
- Pinpoint Asset Management (Singapore) first reported a position in BeOne Medicines Ltd in Q2 2025 and has held it in 5 quarters since.
- Pinpoint Asset Management (Singapore)'s BeOne Medicines Ltd position peaked at $3.95M in Q2 2025.
- 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.
Based on Pinpoint Asset Management (Singapore)'s 13F filing for Q2 2026, filed 6 Aug 2026.